Transverse tubules (T-tubules) play a significant role in muscle contraction. However, the underlying mechanism of their ...
Silexion Therapeutics ( ($SLXN) ) has shared an announcement. On January 6, 2026, Silexion Therapeutics released a CEO letter to shareholders ...
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced interim results from two Phase 1/2a clinical trials of ARO-INHBE and ARO-ALK7, the company’s investigational RNA interference (RNAi) ...
News-Medical.Net on MSN
Artificial intelligence unlocks new frontiers in RNA drug design
In the realm of modern medicine, RNA-based therapies have emerged as a promising avenue, with significant advancements in metabolic diseases, oncology, and preventive vaccines. A recent article ...
The field of skin aging research has undergone a remarkable transformation, evolving from descriptive studies to mechanistic investigations that integrate genetics, molecular biology, and personalized ...
Hypertension remains one of the most pressing global health challenges. Affecting nearly one-third of adults, it is a key contributor to severe cardiovascular events such as heart attacks, strokes, ...
BEIJING and GOTHENBURG, Sweden, Oct. 24, 2025 /PRNewswire/ -- Suzhou Ribo Life Science Co., Ltd. and Ribocure Pharmaceuticals AB (Ribo), today announced that the European Medicines Agency (EMA) has ...
The U.S. Environmental Protection Agency has approved the registration of Norroa, the first-ever RNA-based treatment for varroa mites, the leading threat to honeybee colonies. The new product from ...
When a neuron in our body gets damaged, segments of RNA produce proteins that can help repair the injury. But in neurological disorders such as ALS and spinal muscular atrophy, or following spinal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback